
Reset all filters
01 9Xywav
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 0
Growth (%) : New Launch
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 0
Growth (%) : New Launch
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 535
2020 Revenue in Millions : 15
Growth (%) : 3,407
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 535
2020 Revenue in Millions : 15
Growth (%) : 3,407
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 958
2021 Revenue in Millions : 535
Growth (%) : 79
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 958
2021 Revenue in Millions : 535
Growth (%) : 79
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 1,273
2022 Revenue in Millions : 958
Growth (%) : 33
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 1,273
2022 Revenue in Millions : 958
Growth (%) : 33
Calcium, Magnesium, Potassium, Sodium Oxybates
Main Therapeutic Indication : Sleep
Currency : USD
2024 Revenue in Millions : 1,473
2023 Revenue in Millions : 1,273
Growth (%) : 16